Fig. 4. Localization of activated CaMKII in response to ␣1ARS. Immunofluorescence images of ventricular myocytes labeled with active CaMKII antibody (red;
A and B) and the plasma membrane marker WGA-FITC (green; C and D) before and after ␣1ARS. (E and F) Overlay images demonstrate that active CaMKII localized near the T-tubules and the sarcolemma after ␣1ARS (F). However, immunoreactivity of active CaMKII was found only at the plasmalemma before ␣1ARS (E). (Scale bars in F, 10 m.) www.pnas.org͞cgi͞doi͞10.1073͞pnas.0505477102 PLANT BIOLOGY. For the article ''The power of chemical genomics to study the link between endomembrane system components and the gravitropic response,'' by Marci Surpin, Marcela Rojas-Pierce, Clay Carter, Glenn R. Hicks, Jacob Vasquez, and Natasha V. Raikhel, which appeared in issue 13, March 29, 2005 , of Proc. Natl. Acad. Sci. USA (102, 4902-4907; first published March 16, 2005; 10 .1073͞ pnas.0500222102), the authors note that in Table 1 , the concentrations are incorrectly presented as ''M'' instead of ''M,'' due to a printer's error. The corrected table appears below. In addition, the authors note the last sentence of the Fig. 3 legend, ''Chemical structures are shown in Table 1 ,'' should be removed. The structures now appear online in Table 2 , which is published as supporting information on the PNAS web site. These errors do not affect the conclusions of the article. ␣1-Adrenoceptor stimulation (␣1ARS) modulates cardiac muscle contraction under physiological conditions by means of changes in Ca 2؉ current through L-type channels (ICa,L) and Ca 2؉ sensitivity of the myofilaments. However, the cellular mechanisms of ␣1ARS are not fully clarified. In this study, we investigated the role of Ca 2؉ ͞calmodulin-dependent PK II (CaMKII) in the regulation of ICa,L during ␣1ARS in isolated adult rat ventricular myocytes by using the perforated patch-clamp technique. CaMKII inhibition with 0.5 M KN-93 abolished the potentiation in ICa,L observed during ␣1ARS by 10 M phenylephrine. In the presence of PKC inhibitor (10 M chelerythrine), the potentiation of ICa,L by phenylephrine also disappeared. In Western immunoblotting analysis, phenylephrine (>1 M) increased the amount of autophosphorylated CaMKII (active CaMKII) significantly, and this increase was abolished by CaMKII inhibition or PKC inhibition. Also, we investigated changes in the subcellular localization of active CaMKII by using immunofluorescence microscopy and immunoelectron microscopy. Before ␣1ARS, active CaMKII was exclusively located just beneath the plasmalemma. However, after ␣1ARS, active CaMKII was localized close to transverse tubules, where most of L-type Ca 2؉ channels are located. From these results, we propose that CaMKII, which exists near transverse tubules, is activated and phosphorylated by ␣1ARS and that CaMKII activation directly potentiates I Ca,L in rat ventricular myocytes.
cardiac muscle ͉ perforated patch-clamp ͉ PKC ͉ phenylephrine T he ␣ 1 -adrenoceptor has an important role in the regulation of mammalian cardiac muscle contraction (1, 2) . Recent studies indicate that ␣ 1 -adrenoceptor stimulation (␣ 1 ARS) causes a positive inotropic effect in most mammalian ventricular myocytes (1-3). The proposed mechanisms underlying the positive inotropic effect are as follows: prolongation of action potential duration by inhibition of K ϩ currents (4) and an increase in myofibrillar responsiveness to Ca 2ϩ (1) by intracellular alkalinization (5) and͞or phosphorylation of contractile proteins (6) .
Although Ca 2ϩ current through L-type channel (I Ca,L ) is an important determinant of the Ca 2ϩ transients that trigger contraction, the contribution of I Ca,L to the positive inotropic response to ␣ 1 ARS is not fully clarified. In studies (4, 7) using the whole-cell patch-clamp technique with Ca 2ϩ buffer present in the pipette solution, phenylephrine did not affect I Ca,L . However, in recent studies using the perforated patch-clamp in the absence of Ca 2ϩ buffer, I Ca,L , as well as contractile force and the Ca 2ϩ transient, were potentiated in rat ventricular myocytes (8, 9 One M bupranolol (Kaken Pharmaceutical, Tokyo) was present in the perfusion solution throughout the experiments to block ␤-adrenergic effect (5). The pipette solution contained 130 mM CsCl, 10 mM NaCl, 0.5 mM MgCl 2 , 5 mM Hepes, and 1 mM CaCl 2 , and pH was adjusted to 7.20 with CsOH. All reagents were purchased from Sigma, unless otherwise indicated. KN-93 and KN-92 were obtained from Calbiochem, and 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA)-acetoxymethyl ester was obtained from Molecular Probes. Antiphospho-CaMKII (anti-active CaMKII, rabbit polyclonal IgG raised against threonine phosphorylated peptide corresponding to the phosphorylated Thr-256 region of the mammalian CaMKII) was obtained from Promega (12, 13) . Anti-total CaMKII (mouse monoclonal IgG raised against amino acids 303-478 of CaMKII of mouse origin) was obtained from Santa Cruz Biotechnology (12) . Alexa-546-conjugated anti-rabbit secondary antibody from Molecular Probes. Wheat germ agglutinin (WGA)-FITC from Biomeda (Foster City, CA) and 15 nm of gold-conjugated goat anti-rabbit IgG from Amersham Biosciences.
Measurement of I Ca,L . Perforated patch-clamp was used to measure I Ca,L by using an EPC-8 amplifier (HEKA Electronik, Lambrecht͞Pfalz, Germany) (14-16). For measuring I Ca,L , holding potential was set at Ϫ40 mV, and a 200-msec depolarizing pulse to 0 mV was applied every 10 sec. The current-voltage relationship was obtained by using a series of test pulses between Ϫ30 and ϩ60 mV in 10-mV increments. Current amplitude was defined as the difference between the peak current and the residual current at the end of the pulse. The application of 10 M nifedipine in the perfusate almost completely blocked this current (data not shown), indicating that the measured current was I Ca,L . All experiments were performed at room temperature (Ϸ25°C).
Western Immunoblotting. Contents of total and phosphorylated CaMKII (active CaMKII) were determined by Western immunoblotting using whole-cell protein extracts (12) . Cells were treated with various concentrations of phenylephrine (0-100 M) for 15 min and then protein extracts were prepared. For testing the effect of chemicals (prazosin, KN-93, and chelerythrine) used in electrophysiological experiments, cells were exposed to Tyrode's solution containing these chemicals for 10 min before application of phenylephrine and then to the same solutions containing 10 M phenylephrine for 15 min. Samples (50 g per well) were electrophoresed in 12% SDS͞PAGE gel, transferred to a polyvinylidence difluoride membrane (Bio-Rad) and exposed to primary antibodies against active CaMKII and total CaMKII. Immunoreactive bands were visualized by enhanced chemiluminescence using the ECL-plus detection kit (Amersham Biosciences) and quantified by using densitometry (ATTO, Tokyo). Analysis of the change in total or active CaMKII due to phenylephrine exposure was carried out by comparing the band intensity with that of the control (nonexposed) band.
Immunofluorescence Microscopy. After treatment with 100 M phenylephrine for 15 min, myocytes were fixed in 100% acetone at Ϫ20°C for 10 min, incubated with the primary antibody against active CaMKII and WGA-FITC (overnight), followed by Alexa-546-conjugated anti-rabbit secondary antibody for 1 h (17). Immunostaining was visualized with an LSM-510 laser scanning confocal microscope (Zeiss). Control experiments performed by using secondary antibody without primary antibody showed no noticeable labeling.
Immunoelectron Microscopy. For cryoimmunoelectron microscopy, isolated myocytes were fixed in 2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) infused with 2.3 M sucrose containing 20% polyvinylpyrrolidone at 4°C and frozen in liquid nitrogen. Ultrathin cryosections were cut and processed for immunolabeling (18, 19) . Rabbit anti-active CaMKII IgG as a primary antibody and 15 nm of gold-conjugated goat anti-rabbit IgG as a secondary antibody were used. Samples were examined with an H-7500 transmission electron microscope (Hitachi, Tokyo) at an accelerating voltage of 100 KV. Gold-particle density was determined at the level of the Z lines (representing a T-tubule location) and at the plasmalemma, as described in ref. 20 , with some modifications. Briefly, the density of gold particles within 500 ϫ 500-nm 2 areas of the section was determined for areas located at the level of the Z lines between the myofibrils (233 areas, presumably indicating T-tubule location) and in proximity of the plasmalemma (83 areas) by using sections from four representative single cells before or after ␣ 1 ARS, respectively. The counts were normalized by the particles density on areas of the section within the myofibrils (293 areas, taken as background).
Statistics. All data are presented as mean Ϯ SD. Bars indicate SD. Statistical comparisons were carried out by using one-way or one-way repeated measured ANOVA followed by Bonferroni post hoc test with the significance level set at P Ͻ 0.05.
Results

Effect of 10 M Phenylephrine on ICa,L Measured by Using the
Perforated Patch-Clamp Technique. Fig. 1 shows a representative result of the effect of 10 M phenylephrine on I Ca,L . The effect of phenylephrine on the Ca 2ϩ responsiveness of the contractile element in rat ventricular myocytes is almost saturated at this concentration (5) . As reported (8, 9), we observed a transient decrease followed by a sustained increase of I Ca,L amplitude. As shown in Fig. 1 A, I Ca,L transiently decreased for up to 2 min after the application of phenylephrine, and then it gradually increased and reached another steady-state level at Ϸ15 min after this application. The amplitudes of I Ca,L at 15 and 20 min were not statistically different (114.8 Ϯ 14.5% of control and 117.9 Ϯ 13.5% of control, n ϭ 12, P ϭ 1.00), and thus, the effect of 10 M phenylephrine on I Ca,L potentiation reached a steady state at 15 min. The amplitude of I Ca,L returned to the control level at 10 min after removal of phenylephrine (101.4 Ϯ 6.2% of control, n ϭ 5, P ϭ 0.678). The initial transient decrease in I Ca,L at 2 min (91.4 Ϯ 6.0% of control, n ϭ 12, P Ͻ 0.05) and the later increase at 15 min (114.8 Ϯ 14.5% of control, n ϭ 12, P Ͻ 0.001) (Fig. 1C) were small but significant. The increase in I Ca,L occurred without changes in the shape of the current-voltage relationship (Fig.  1B) . These negative and positive effects of phenylephrine on I Ca,L were both completely blocked by the ␣ 1 -adrenoceptor antagonist prazosin (1 M) (n ϭ 12, data not shown). In the absence of phenylephrine, the amplitude of I Ca,L was stable for up to 15 min (Fig. 1C) .
We explored the effect of intracellular Ca 2ϩ buffering on I Ca,L in response to 10 M phenylephrine (Fig. 1D) . After establishing perforated patch, a cell was incubated with 20 M BAPTAacetoxymethyl ester, the cell permeable form of BAPTA, for 10 min and we confirmed that the cell did not contract during the pulse to evoke I Ca,L (16) . In this condition, phenylephrine did not show either a significant transient decrease in I Ca,L at 2 min (97.2 Ϯ 4.4% of control, n ϭ 10, P ϭ 1.00) or a sustained increase at 15 min (101.3 Ϯ 17.1% of control, n ϭ 10, P ϭ 1.00). Thus, intracellular Ca 2ϩ is a key factor for the potentiation in I Ca,L induced by phenylephrine. The different responses of I Ca,L to phenylephrine recorded by conventional patch and perforated patch can be explained by the intracellular Ca 2ϩ concentration.
The Role of CaMKII in the Regulation of ICa,L by ␣1ARS. Recent studies have reported that CaMKII is involved in various Ca 2ϩ -dependent effects both under physiological and pathophysiological conditions in mammalian ventricular myocytes (10) . Thus, we investigated the role of CaMKII in the regulation of I Ca,L by ␣ 1 ARS by using KN-93, a synthetic CaMKII inhibitor. At a concentration of 0.5 M, KN-93 selectively inhibits CaMKII without affecting other PKs (21) . A 10-min exposure to 0.5 M KN-93 significantly decreased I Ca,L from 9.12 Ϯ 3.27 to 5.50 Ϯ 3.39 pA͞pF, corresponding to 39.1 Ϯ 25.6% decrease (n ϭ 12, P Ͻ 0.001) without changing the shape of the current-voltage relationship (n ϭ 10) (see also ref. 22 ). In the presence of KN-93, 10 M phenylephrine produced only a sustained decrease of I Ca,L ( Fig. 2A) . At 15 min after application of 10 M phenylephrine, the amplitude of I Ca,L significantly decreased to 66.7 Ϯ 22.0% of the value before application of phenylephrine in the presence of KN-93 (n ϭ 12, P Ͻ 0.001) without changing the shape of the current-voltage relationship (n ϭ 10). In contrast, 0.5 M KN-92, an inactive KN-93 analogue, did not show significant effects on the biphasic change of I Ca,L caused by ␣ 1 ARS (Fig. 2 A) . We also investigated the effect of 10 M phenylephrine in the presence of another CaMKII inhibitor, autocamtide-2 inhibitory peptide, a membrane-permeable and a highly specific peptide type inhibitor of CaMKII (23). When we used 10 M autocamtide-2 inhibitory peptide, 10 M phenylephrine produced only a sustained decrease of I Ca,L without potentiation as in the presence of KN-93 (n ϭ 5, data not shown). Thus, CaMKII inhibition abolished the potentiation of I Ca,L during ␣ 1 ARS.
The Role of PKC in the Regulation of ICa,L During ␣1ARS. PKC may be involved in the ␣ 1 -adrenoceptor-mediated modulation of cardiac K ϩ channels, intracellular alkalinization and myofibrillar responsiveness to Ca 2ϩ (2) . Therefore, we investigated the role of PKC in the regulation of I Ca,L by ␣ 1 ARS by using chelerythrine as a PKC inhibitor. We found that 10 M chelerythrine selectively inhibits PKC without affecting other PKs (24) and effectively blocks the effect of phenylephrine on the Ca 2ϩ responsiveness of the contractile element (5). Exposure to 10 M chelerythrine for 10 min significantly decreased I Ca,L to a new steady state from 7.42 Ϯ 1.61 to 3.78 Ϯ 1.23 pA͞pF, corresponding to a 49.7 Ϯ 13.2% decrease (n ϭ 9, P Ͻ 0.001) without changing the shape of the current-voltage relationship. In the presence of chelerythrine, 10 M phenylephrine produced only a sustained decrease of I Ca,L as observed in the presence of CaMKII inhibitors (Fig. 2B) . At 15 min after application of 10 M phenylephrine, the amplitude of I Ca,L decreased to 42.3 Ϯ 10.9% of the value before application of phenylephrine in the presence of chelerythrine (n ϭ 9, P Ͻ 0.001) (Fig. 2B ) without changing the shape of the current-voltage relationship (n ϭ 9).
Activation of CaMKII During ␣1ARS. Our electrophysiological experiments suggest that potentiation of I Ca,L in response to ␣ 1 ARS is mediated by both CaMKII and PKC. Although PKC has been suggested to be involved in the ␣ 1 -adrenoceptor signaltransduction pathway (2), there are no reports that CaMKII is activated by ␣ 1 ARS in rat ventricular myocytes. The amount of CaMKII is low compared with other PKs; consequently, it is difficult to determine CaMKII activity directly in cardiac muscle (25) . To overcome this difficulty, we used an antibody against the autophosphorylation site of CaMKII, Thr-286, and an enhanced chemiluminescence system to measure CaMKII activity in whole-cell lysates in response to ␣ 1 ARS (12, 13) . Active CaMKII increased significantly at concentrations of Ն1 M phenylephrine (Fig. 3A Bottom) , although total CaMKII was not altered (Fig. 3A Top; data not shown). The increase of active CaMKII level induced by 10 M phenylephrine was completely blocked by the ␣ 1 -adrenoceptor antagonist prazosin (1 M), showing that this effect was mediated by ␣ 1 -adrenoceptor (Fig. 3B) . The selective CaMKII inhibitor 0.5 M KN-93 that we used in the perforated patch experiments partially blocked the basal CaMKII activity in the absence of phenylephrine and also completely blocked the increase in the active CaMKII level by 10 M phenylephrine (Fig. 3C) .
To determine whether PKC could be a regulator of CaMKII activation during ␣ 1 ARS, the effect of phenylephrine in the presence of chelerythrine on CaMKII activity was determined. Chelerythrine (10 M) did not produce significant changes in the CaMKII activation before phenylephrine (86.6 Ϯ 25.1% of control, n ϭ 7, P ϭ 0.39). However, the increase in active CaMKII by 10 M phenylephrine was abolished by chelerythrine (102.2 Ϯ 24.3% of control, n ϭ 7, P ϭ 1.00), as in the case of KN-93, indicating that PKC is involved in the activation of CaMKII during ␣ 1 ARS (Fig. 3D) .
Immunocytochemical Localization of Active CaMKII by ␣1ARS. It has been reported that CaMKII may directly phosphorylate the L-type Ca 2ϩ channel and regulate the positive feedback system that facilitates I Ca,L under physiological conditions (17, 26) . Our biochemical experiments showed that CaMKII is significantly activated by ␣ 1 ARS in adult rat isolated ventricular myocytes. To investigate whether CaMKII could directly regulate the L-type Ca 2ϩ channel during ␣ 1 ARS, we determined the localization of active CaMKII in isolated ventricular myocytes by using immunofluorescence microscopy, as shown in Fig. 4 . We used WGA-FITC, a marker of sarcolemma including T-tubules (27) , and anti-active CaMKII antibody to establish the intracellular localization of active CaMKII (Fig. 4 C and D) . Before ␣ 1 ARS, active CaMKII was detectable at the plasmalemma (Fig. 4 A and E) as reported (17) . After ␣ 1 ARS (100 M phenylephrine) active CaMKII was still present at the plasmalemma (Fig. 4B) , but it was also clearly visible along transverse bands that coincide with the location of WGA-FITC. This result suggests that a higher level of active CaMKII was localized at or near the T-tubules after ␣ 1 ARS than in the resting state (Fig. 4F) .
To confirm the subcellular localization of active CaMKII before and after ␣ 1 ARS, immunoelectron microscopy was used. The number of gold particles over a standard area (SA) at the plasmalemma and at the level of the Z lines where T-tubules are located was counted in sections from four representative cells before and after ␣ 1 ARS. Before ␣ 1 ARS, the frequency of gold particles was very low both beneath the plasmalemma (0.10 Ϯ 0.31 particles per SA, 0.39 Ϯ 1.20 in normalized density, n ϭ 30 areas) and at T-tubules (0.09 Ϯ 0.29 particles per SA, 0.36 Ϯ 1.15 in normalized density, n ϭ 108 areas) (Fig. 5D ). After applica- Figs. 4F and 5E ). In contrast, the particle density beneath the plasmalemma remained low (0.49 Ϯ 0.80 particles per SA, 1.60 Ϯ 2.61 in normalized density, n ϭ 53, P ϭ 0.27, compared with that before ␣ 1 ARS) (Fig. 5C) . Thus, immunogold labeling showed Ϸ2.5-fold enrichment of active CaMKII in T-tubules compared with the plasmalemma after ␣ 1 ARS (Fig. 5E ). The particle density in the myofibrils areas was not significantly different before (0.25 Ϯ 0.48 particles per SA, n ϭ 110) and after ␣ 1 ARS (0.30 Ϯ 0.52 particles per SA, n ϭ 183).
There seems to be a discrepancy between the results obtained by using light and electron microscopy regarding the location of active CaMKII in the resting cells. The light-microscope images did not show active CaMKII at T-tubules, whereas electronmicroscopic images detected a very low level at those sites. The confocal sections are relatively thick compared with the thickness of the T-tubules so that a small portion of each section is occupied by T-tubule membrane and a weak signal in this membrane is not detected. In contrast, the plasmalemma runs from one end of the section to the other, so that the signal from this membrane is detectable even if weak. In the thin sections for electron microscopy, plasmalemma and T-tubule membrane are more equally represented.
Discussion
In this study, we explored the involvement of CaMKII in the signal transduction pathway between ␣ 1 ARS and the potentiation of I Ca,L in rat ventricular myocytes, and we show direct evidence indicating that CaMKII is activated by ␣ 1 ARS and has an important effect on I Ca,L .
Our electrophysiological experiments using the perforated patch technique confirm the reported (8, 9) potentiation of I Ca,L during ␣ 1 ARS in rat ventricular myocytes. When I Ca,L is measured by using the whole-cell patch-clamp technique, phenylephrine does not affect I Ca,L at any concentrations (4, 7), and we can mimic this effect by buffering the intracellular Ca 2ϩ with BAPTA-acetoxymethyl ester. Thus, intracellular Ca 2ϩ concentration is essential for the potentiation of I Ca,L during ␣ 1 ARS. This result is consistent with the report that basal intracellular Ca 2ϩ is sufficient for the initial CaMKII activation under physiological condition (28) .
We chose 10 M phenylephrine in our electrophysiological experiments because the effect of phenylephrine on I Ca,L potentiation is saturated at this concentration (see Fig. 6 , which is published as supporting information on the PNAS web site). ␣ 1 ARS has two opposite effects on I Ca,L . (i) Higher concentration of phenylephrine (Ն10 M) cause a biphasic response: an initial brief (Ϸ2 min) depression, or negative phase, followed by a potentiation or positive phase; and (ii) lower concentration of phenylephrine (Ն1 M) cause a monophasic positive effect (Fig. 6) . The positive effect (potentiation) depends on CaMKII activation and PKC activation because CaMKII inhibition or PKC inhibition abolished the potentiation of I Ca,L (Fig. 2 and Fig. 7 , which is published as supporting information on the PNAS web site). There is less information about the negative effect of ␣ 1 ARS on I Ca,L . In these experiments, we focused on the potentiation of I Ca,L during ␣ 1 ARS (positive effect).
Our electrophysiological experiments using CaMKII inhibitors demonstrated the important role of CaMKII in the potentiation of I Ca,L (positive phase) during ␣ 1 ARS in cardiac myocytes. Western immunoblot analysis confirmed an increase in active CaMKII (see also ref. 13 ) in parallel with the potentiation of I Ca,L . Also, we showed that PKC, which is activated by the Gq-phospholipase C-diacylglycerol pathway (2) , is involved in the activation of CaMKII during ␣ 1 ARS, based on the similar effects of CaMKII and PKC inhibition on I Ca,L in the presence of phenylephrine. It has been reported that, in resting cardiac myocytes, there is significant activation of CaMKII but active CaMKII can be lost when the intracellular Ca 2ϩ concentration is lowered to very low levels by removal of extracellular Ca 2ϩ (17) . Basal activity of CaMKII is determined mainly by the resting intracellular Ca 2ϩ level (and not by the PKC activity). However, after ␣ 1 ARS, PKC activity has an important role in the additional and sustained (A and B) , and a lower intensity of gold labeling was observed just beneath the non-T-tubular surface sarcolemmal membrane (C). (D) No gold labeling was observed directly under T-tubules membrane before ␣1ARS. CM, cell membrane; MT, mitochondrion; Z, Z line. (Scale bar, 500 nm.) (E) Normalized gold particles density in T-tubules (n ϭ 108 areas counted before ␣1ARS and n ϭ 125 areas counted after ␣1ARS) and sarcolemma (n ϭ 30 areas counted before ␣1ARS and n ϭ 53 areas counted after ␣1ARS) relative to the surface areas on the myofilaments (n ϭ 110 areas counted before ␣1ARS and n ϭ 183 areas counted after ␣1ARS). The calculation method for normalized gold particles density is described in Materials and Methods. (Bars in E indicate SD.) *** , P Ͻ 0.001. activation of CaMKII. PKC can directly phosphorylate the autophosphorylation site of CaMKII in vitro, thus directly increasing CaMKII activity (29) . This report strongly supports our hypothesis that there is a physiological linkage between PKC and CaMKII during ␣ 1 ARS.
Immunolabeling at the ultrastructural level demonstrates that the level of active CaMKII is very low along the plasmalemma and T-tubules in the resting cells but increases significantly along the T-tubules, where L-type Ca 2ϩ channels are mostly present (11), after ␣ 1 ARS. The correspondence between the distributions of active CaMKII and L-type Ca 2ϩ channels strongly supports our view that CaMKII directly phosphorylates the L-type Ca 2ϩ channels and potentiates I Ca,L in response to ␣ 1 ARS. Immunofluorescence microscopy confirms the increase in active CaMKII at the T-tubules from an undetectable to a detectable level with stimulation.
It has been reported (10) that CaMKII modulates I Ca,L under physiological conditions. Several groups have demonstrated that Ca 2ϩ -dependent I Ca,L facilitation is mediated by CaMKIIdependent phosphorylation of L-type Ca 2ϩ channel, and this mechanism is considered to be related to the positive staircase of I Ca,L induced by repeated depolarization from physiological holding potential (17, 26, 30) . However, the molecular mechanisms of how I Ca,L is potentiated by the activation of CaMKII have not been elucidated.
In summary, these experiments show that (i) ␣ 1 ARS potentiates I Ca,L by PKC and CaMKII activation and (ii) activated CaMKII is highly localized close to the T-tubules after ␣ 1 ARS.
